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Abstract Disposable bioreactors have increasingly been
incorporated into preclinical, clinical, and production-scale
biotechnological facilities over the last few years. Driven
by market needs, and, in particular, by the developers and
manufacturers of drugs, vaccines, and further biologicals,
there has been a trend toward the use of disposable seed
bioreactors as well as production bioreactors. Numerous
studies documenting their advantages in use have contrib-
uted to further new developments and have resulted in the
availability of a multitude of disposable bioreactor types
which differ in power input, design, instrumentation, and
scale of the cultivation container. In this review, the term
“disposable bioreactor” is defined, the benefits and con-
straints of disposable bioreactors are discussed, and critical
phases and milestones in the development of disposable
bioreactors are summarized. An overview of the disposable
bioreactors that are currently commercially available is
provided, and the domination of wave-mixed, orbitally
shaken, and, in particular, stirred disposable bioreactors in
animal cell-derived productions at cubic meter scale is
reported. The growth of this type of reactor system is
attributed to the recent availability of stirred disposable
benchtop systems such as the Mobius CellReady 3 L
Bioreactor. Analysis of the data from computational fluid
dynamic simulation studies and first cultivation runs
confirms that this novel bioreactor system is a viable
alternative to traditional cell culture bioreactors at benchtop
scale.
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Introduction
According to Chmiel (2006), a bioreactor is a closed
system in which the production organism expresses the
product of interest while controlled process conditions are
guaranteed. In the case of a disposable bioreactor, the
cultivation container is typically made from a plastic
approved by the Food and Drug Administration (e.g.,
polyethylene, polystyrene, polytetrafluorethylene, polypro-
pylene (PP), or ethylene vinyl acetate; Eibl and Eibl 2006)
and not glass or stainless steel, as was the case in
traditional designs. In its simplest configuration, the
disposable bioreactor consists of just a non-instrumented
cultivation container and hence requires an external device
(e.g., CO2 incubator, shaker) to provide the optimal
environment for cell growth and/or product formation.
Such a system is suitable primarily for small volume
cultivations at milliliter scale. Disposable bioreactors
operating with culture volumes of 1 L or more are used
preferably with their own unit for measurement and
control of relevant process parameters. This means that
they are equipped with disposable and/or standard online
sensors allowing, for example, monitoring of temperature,
pH, and dissolved oxygen (DO).
The advantages of disposable bioreactors such as high
flexibility, easy handling, reduced incidence of cross-
contamination, and savings in time and costs (Lim and
Sinclair 2007; Foulon et al. 2008; Behme 2009; Mauter
2009) are ascribed to the pre-sterility of the cultivation
container which is guaranteed by the vendor. Critical issues
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currently restricting the use of disposable bioreactors arise
from the limited experience of using such bioreactors,
insufficient plastic material strength, in addition to scal-
ability and the single-use philosophy itself (Eibl and Eibl
2008a). Renewal of the disposable cultivation container
also contributes to an increase in the costs of solid waste
disposal and consumables, resulting in higher running
costs, thereby limiting the adoption of advanced automated
solutions. In addition, the commercial availability of
reliable, disposable sensors (Rao et al. 2009) for the
measurement and control of the main process parameters
and peripheral elements, such as valves, sampling systems,
and couplers, is restricted. A further limiting factor is the
time required to train staff in order to ensure trouble-free
operation of disposable bioreactors, which may increase as
disposable bioreactors of larger culture volume are used.
However, the most controversial issue has been the
detection of extractables and leachables (van Tienhoven et
al. 2006; Altaras et al. 2007; Jenke 2007; Okonkowski et al.
2007) which can interact with the product.
Notwithstanding the constraints mentioned above, dis-
posable bioreactors possessing either a rigid (tube, plate,
flask, cylindrical vessel) or a flexible (bag) cultivation
container have gained importance as will be discussed in
the summary of their development. An assessment of the
disposable bioreactors currently available including their
power input, type, scale, as well as application confirms the
current popularity of mechanically driven and, in particular,
stirred disposable bioreactor systems. The Mobius Cell-
Ready 3 L bioreactor is a recently introduced example of
such a bioreactor system which was used for Chinese
hamster ovary (CHO) cell cultivations and computational
fluid dynamic (CFD) simulations, the results of which are
both presented for the first time in this paper. Finally,
current trends in the selection of disposable bioreactors are
summarized.
Development phases and milestones
Phase 1
The development of disposable bioreactors can be de-
scribed in three phases. Phase 1 covering the early
beginnings dates back nearly 50 years. At this time, glass
Petri dishes had already been replaced by their plastic
counterparts in many microbial laboratories. In 1963, Falch
and Heden (Falch and Heden 1963) at the Karolinska
Institute in Stockholm reported the successful application of
shaken tetrahedron bags made of PP and Teflon which had
been made in their own laboratory. Interestingly, they
observed excellent growth for Bacillus subtilis, Escherichia
coli, and Serratia marcescens cells.
Phase 2
Approximately 10 years later, development phase 2 saw the
introduction of hollow fiber technology by Knazek and his
team (Knazek et al. 1972). The resulting hydraulically
driven hollow fiber bioreactor systems were favored for
continuous in vitro production of hybridoma-derived
monoclonal antibodies (mAbs) at low volume scale
(100 mg to several grams) in the 1980s and 1990s
(Hopkinson 1985; Gorter et al. 1993; Marx 1998; Davis
2007a). Also in phase 2, multi-tray cell culture systems
such as the Cell Factory and the CellCube (Beeksma and
Kompier 1995; Schwander and Rasmusen 2005) and two-
compartment dialysis membrane bioreactors such as the
CELLine and the MiniPerm (Falkenberg 1998; Trebak et al.
1999; Bruce et al. 2002; McArdle 2004) were introduced
into animal cell culture labs. Whereas Cell Factories
replaced plastic roller bottles and proved to be suitable for
the commercial GMP manufacture of a few vaccines and
therapeutic proteins (Hagen et al. 1996; Aunins et al. 1997;
Davis 2007b; Ball et al. 2009), two-compartment dialysis
bioreactors became recognized as appropriate for long-term
cell expansions, screening experiments, and sample pro-
duction at milliliter scale (Nagel et al. 1999; Docagne et al.
2001; Scott et al. 2001; Eibl and Eibl 2007; Adam et al.
2008). Toward the end of phase 2, the suitability of
pneumatically driven plastic bag bioreactors (bubble col-
umn type) with minimal instrumentation (Life Reactor,
Ebb-and-Flow Bioreactor, Plastic-lined Bioreactor) for
plant cell-derived secondary metabolite expressions was
demonstrated (Ziv et al. 1998; Curtis 1999, 2004; Hsiao et
al. 1999; Ziv 1999, Ziv 2000, 2005).
Phase 3
The launch of the first wave-mixed bag bioreactor system in
the late 1990s marked the start of, and influenced the course
of, development phase 3, which led to the disposable
bioreactor types listed in Table 1. The disposable bioreactors
are differentiated based on the type of power input and
encompass mechanically driven/wave-mixed, mechanically
driven/stirred, mechanically driven/orbitally shaken, mechan-
ically driven/vertically oscillating, pneumatically driven, and
hybrid systems.
Mixing within the multilayer bags of the wave-mixed
bioreactors listed in Table 1 is achieved through a wave-
induced mixing process, resulting from the oscillating
movement of a platform or of platform sections. Due to
the wave movement, oxygen is incorporated in the fluid
from the headspace within the bag without the formation of
bubbles. The seven, wave-mixed, bag bioreactor systems
are distinguished by their control mechanism, their bag
design, the installed sensor types, the type of platform
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Table 1 Summary of main disposable bioreactors coming onto the market in phase 3
Bioreactor brand Vendor Maximum size Main applications
Mechanically driven/wave-mixed (horizontally oscillating)
BIOSTAT CultiBag RM
(in the past BioWave)
Sartorius Stedim 300 L CV Cultivation of animal cells, plant cells and microorganisms having
up to medium oxygen demands: screening, seed inoculum
production, small and medium volume scale manufacture
Wave Bioreactor GE Healthcare 500 L CV
AppliFlex Applikon 25 L CV
Tsunami Bioreactor TsunamiBio 160 L CV per
platform
CELL-tainer Bioreactor, animal Lonza 15 L CV Cultivation of animal cells and plant cells: screening,
seed inoculum production, sample production,
small volume scale manufacture
CELL-tainer Bioreactor,
microbial
Cultivation of microorganisms: screening, seed inoculum
production, sample production, small volume scale manufacture
WUB Nestlé 100 L CV Cultivation of plant cells: small and medium volume
scale manufacture
Mechanically driven/vertically oscillating
BayShake Bioreactor Bayer Technology
Services/Sartorius
Stedim
1,000 L TV Cultivation of animal cells: seed inoculum production, sample
production, small and medium volume scale manufacture
Mechanically driven/orbitally shaken
µ24 Microbioreactor Applikon 7 mL TV Cultivation of animal cells, plant cells and microorganisms:
screening
BioLector mp2-labs 1.5 mL TV
CultiFlask 50 DBa Sartorius Stedim 35 mL CV
Sensolux 1 L TV
SB-200X Disposable Shaken
Bioreactor System
Kühner/Sartorius
Stedim
200 L TV Cultivation of animal cells: seed inoculum production,
sample production, small and medium volume scale manufacture
CURRENT Bioreactor AmProtein 300 L CV
Mechanically driven/stirred
S.U.B. ThermoFisher Scientific 1,000 L CV Cultivation of animal cells: seed inoculum production,
small and medium volume scale manufacture
BIOSTAT CultiBag STR Sartorius Stedim 1,000 L CV
Nucleo Bioreactor ATMI Life Science 1,000 L CV
XDR-DSTB, animal Xcellerex 2,000 L CV
XDR-DSTB, microbial 200 L TV Manufacture of microbial HCD products
Mobius CellReady 3 L Bioreactor Applikon/Millipore 3 L TV Cultivation of animal cells: screening, seed inoculum
production, sample production
CelliGen BLU SUB New Brunswick 14 L TV
SuperSpinner D1000a Sartorius Stedim 1 L CV
Pneumatically driven
SBB Nestlé 100 L CV Cultivation of plant cells: small and medium volume scale
manufacture
PBS PBS 250 L TV Cultivation of animal cells: seed inoculum production, sample
production, small- and medium-volume-scale manufacture
CellMaker Regular
(in the past CellMaker Lite)
Cellexus 50 L CV Cultivation of microorganisms: seed inoculum production,
sample production, small-volume-scale manufacture
Hybrid
CellMaker Plus Cellexus 8 L CV Cultivation of animal cells: seed inoculum production,
sample production
CV culture volume, DB disposable bioreactor, DSTB disposable stirred tank bioreactor, HCD high cell density, PBS Pneumatic Bioreactor System,
SBB Slug Bubble Bioreactor, SUB Single-Use Bioreactor, TV total volume, WUB Wave and Undertow Bioreactor
a Non-instrumented
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movement, and the number of platforms. However, cell
growth and product expression are always controlled via
mass and energy transfer which can be adjusted, with the
exception of the WUB and CELL-tainer, by modifying the
rocking rate, rocking angle, filling level, and aeration rate
of the moving bag. In the case of the WUB, mixing and
aeration occur through periodic upward and undertow
movement of movable sections of a horizontal platform
(table) on which the bag is located. The parameters
influencing mass and energy transfer in a WUB bag are
the angle of the platform, the proportion of the culture
volume located on, and lifted by, the platform, the aeration
rate, and the time taken for the platform to complete one
oscillation (Girard et al. 2006; Terrier et al. 2007). In
contrast, the platform movement of a CELL-tainer Biore-
actor is two-dimensional, which is accomplished by
additional horizontal displacement, resulting in volumetric
oxygen transfer rates 10 to 60 times higher than in other
wave-mixed systems (Lonza 2008). In fact, CELL-tainer
Bioreactor’s microbial version provides the highest volu-
metric oxygen transfer rates (above 200 per hour) reported
to date for wave-mixed systems (Lonza 2008). Thus, the
microbial version of the CELL-tainer Bioreactor is pre-
ferred for limitation-free, high cell density cultivations of
microorganisms having high oxygen demands.
Wave-mixed bag bioreactors are well suited to small-
and medium-scale processes where cells with low to
medium oxygen demands are cultivated in batch, feeding,
and perfusion modes. In addition to seed inoculum,
biologically active cells (Hami et al. 2003, 2004), mAbs
as well as other therapeutic glycoproteins (Singh 1999;
Oashi et al. 2001; Weber et al. 2002; Eibl et al. 2003a,b;
Pierce and Shabram 2004; Fries et al. 2005) and viruses for
vaccines and gene therapies (Genzel et al. 2004, 2006; Rios
2006; Slivac et al. 2006; Hundt et al. 2007; Negrete and
Kotin 2007) can be generated by growing mammalian or
insect cells in suspension or on microcarriers. Moreover,
plant cell-derived secondary metabolites (Eibl and Eibl
2002; Palazόn et al. 2003; Bentebibel et al. 2005),
microbial niche products such as an immunomodulator
(Eibl et al. 2003b), chiral building blocks (Jablonski-Lorin
et al. 2003), or a Listeria monocytogenes human papillo-
mavirus vaccine (Hitchcock 2009), biological insecticides
(Canales et al. 2001; Hess et al. 2002), and mass-
propagated insecticidal nematodes (Hirschy et al. 2001)
can be successfully produced in wave-mixed bioreactors.
Recent investigations have even confirmed their suitability
for the cultivation of non-Newtonian culture broths as in the
case of fast growing tobacco (BY-2) cells, which have
become popular for plantibody production (Ducos et al.
2008; Eibl et al. 2009a,b).
The BayShake Bioreactor, which has recently been
introduced, achieves gentle mixing and surface aeration
through oscillation, just as in the case of the wave-mixed bag
bioreactors. However, the culture broth in this bioreactor,
designed to produce animal cell-derived products, oscillates
vertically in a cube-shaped bag (Kauling et al. 2007). The
BayShake Bioreactor, the three pneumatically driven bag
bioreactor versions, the SBB (Ducos et al. 2008; Eibl et al.
2009a), the PBS (B. Lee, PBS, October 2009, personal
communication) and the CellMaker Regular (Peacock and
Auton 2008), as well as the hybrid CellMaker Plus (in
which the pneumatic and mechanical power input are
combined; Taylor 2007) are less common than the orbitally
shaken and stirred disposable systems described below.
The discovery that animal cells, just like plant cells and
microorganisms, can be grown without damage due to
shear stress and without oxygen limitation in non-
instrumented, shaking, multiwell plates, and “Erlenmeyer”
flasks resulted in the widespread application of these
systems for high-throughput screening experiments at
milliliter scale. In addition, the publishing of key engineer-
ing parameters (Büchs et al. 2000; Maier et al. 2003; Zhang
et al. 2005; Peter et al. 2006) and the availability of the first
disposable sensors enabled the development of fully
characterized, stand-alone systems such as the µ24 Micro-
bioreactor, the BioLector, and the Sensolux. A further
important contribution to the application of orbitally shaken,
disposable bioreactors in mammalian cell-derived processes
was the invention of the TubeSpin cultivation vessel (trade
name CultiFlask 50 disposable Bioreactor, distribution by
Sartorius Stedim), which is a non-instrumented 50-mL
centrifuge tube with a conical bottom and a ventilated cap.
Despite its simple design, this system delivers cell densities
and product titers comparable to highly instrumented,
reusable stirred bioreactors and wave-mixed bioreactors
when used for animal suspension cell cultivations (De Jesus
et al. 2004; Muller et al. 2004; Ries et al. 2009).
Investigations of oxygen transfer confirmed the feasibility
of using orbital shaker technology for the cultivation of
mammalian cells at scales up to 1,000 L culture volume (Jia
et al. 2008; Potera 2009, Zhang et al. 2009), which enabled
the development of the SB200-X Disposable Shaken
Bioreactor System (Anderlei et al. 2009) and the CUR-
RENT Bioreactor product line from AmProtein.
Stirred disposable bioreactors are to date the most
commonly used disposable bioreactors, although the first
models only came onto the market in 2006. Since
traditional stirred bioreactors represent the most commonly
used, best characterized, and optimized reactor types in
biotechnological production processes (Fenge and Lüllau
2006), this is not unexpected. At the time of writing, there
are eight stirred disposable bioreactor types commercially
available which differ in the design of their cultivation
containers, being either flexible bags or rigid cylindrical
vessels, and on the scale of their operation.
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Stirred disposable bioreactors
Stirred bag systems for pilot and production scale
Stirred bag systems, such as the XDR-DSTB (animal) and
the S.U.B., are the stirred disposable bioreactors that have
been available the longest, and consequently, they hold the
market-leading position. Both systems, which are designed
for animal cells, utilize cylindrical bags in which axial flow
impellers and common aeration devices, such as micro-
spargers or open-pipe spargers, gas filters, and ports for
the integration of sensor probes and line sets are all pre-
installed. The relevant design criteria such as container
geometries and/or impeller geometries and positioning are
replicated from their steel counterparts. The top-driven,
sealed S.U.B. and the magnetically coupled, bottom-driven
XDR-DSTB (animal) are commonly used in many seed
train expansions, mAb, and vaccine productions in which
mammalian and insect cells are grown. Comparable product
quality, product quantities (medium to high cell densities,
protein titers in g-range), and engineering parameters to
those achieved with stirred cell culture bioreactors made of
stainless steel have clearly been demonstrated in numerous
cultivation studies completed by such companies as Baxter,
Centocor, Sanofi-Aventis, and Lonza (Ozturk 2007; Tollnik
2009; Valentine 2009). In addition, the application of the
50L S.U.B. for BY-2 cell-based antibody expression has
recently been described (Eibl et al. 2009a), even though the
S.U.B. design (in the case in question, with microsparger
and pitched blade impeller) is not ideally suited to fast-
growing plant cells (Eibl and Eibl 2008b). It should also be
mentioned that Xcellerex produced the world’s first 2,000-L
system which is the largest disposable bioreactor to date
(Mardirosian et al. 2009). In addition, the company now
offers the first version of a stirred bag bioreactor for microbial
production which has successfully completed initial tests
(with E. coli, Saccharomyces cerevisiae, Pseudomonas
fluorescens) at Pfěnex (Galliher 2008; P. Galliher, Xcellerex,
November 2009, personal communication).
BIOSTAT CultiBag STR The top-driven BIOSTAT CultiBag
STR, which can be connected to the BioPAT MFCS/Win
SCADA software system, is very similar in configuration to
the classic, reusable, stirred cell culture bioreactor (DeWilde
et al. 2009), an observation which is supported for the 200-L
system by the mixing time, volumetric oxygen transfer rate,
tip speed, and specific power input data achieved, all
measured at typical process conditions for animal cells. In
this system, homogeneous mixing is achieved by a central
stirring system consisting of two axial flow, three-blade
segment impellers, or a combination of one axial flow, three-
blade segment impeller, and one radial flow six-blade
segment impeller. In addition, the bag can be equipped with
a microsparger or sparger ring.
Nucleo Bioreactor The Nucleo Bioreactor incorporating the
following special features, a cube-shaped bag, a tumbling
impeller (Pad-Drive Mixing System), and dynamic sparging
instead of a static structure, produced favorable results for
mammalian cells in fed batch and perfusion cultivations
(Castillo and Vanhamel 2007; Zambaux 2007). Product
titers between 30% and 50% higher than with stirred steel
bioreactors were observed in Nucleo Bioreactors running a
vaccine manufacture with microcarriers. These results are
due to the improved oxygen transfer and lower shear stress
achieved in the Nucleo system (N. Sevé, Sanofi Aventis,
October 2009, personal communication).
Stirred rigid plastic systems for laboratory scale
SuperSpinner D1000 Among stirred, rigid plastic systems,
the SuperSpinner D1000, developed from Lehmann’s
Fig. 1 Mobius CellReady 3 L
Bioreactor. a Product picture
(with kind permission of
Millipore). b Velocity profile
estimated with CFD. For
improved clarity, all built-in
components have been faded out
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(Lehmann et al. 1992) early glass version, has a key
position. It is neither an instrumented nor a stand-alone
system. SuperSpinner D1000’s bubble-free aeration is
achieved through the use of a hollow fiber membrane
wound around a tumbling impeller. Interestingly, this active
aeration provides volumetric oxygen transfer rates approx-
imately 3.5 times greater and cell densities up to three times
greater than glass standard spinners with surface aeration
for animal suspension cells at 1 L culture volume. Based on
trials completed by the authors, it can be confirmed that
similar growth and metabolite courses to wave-mixed
bioreactors are achievable in the SuperSpinner D1000 (Eibl
et al. 2009b), thus making this system suitable for exceeding
cell expansion (e.g., preclinical sample production) of
animal cells.
Mobius CellReady 3 L Bioreactor The Mobius CellReady
3 L Bioreactor (Fig. 1a) is the first disposable stirred
bioreactor available for use at benchtop scale with cultiva-
tions being performed in rigid plastic containers, as is the
case with the SuperSpinner D1000 and the CelliGen BLU
SUB. In trials performed by the authors, vessels having a
total volume of 3 L (2.4 L culture volume) were used, each
being equipped with a three-blade marine impeller and a
microsparger (Millipore 2009). Standard sensors for pH and
sensors for DO and temperature from ez-Control (Applikon
Biotechnology) were used to achieve process control.
Interestingly, the dominance of the impeller’s radial flow
component (Fig. 1b) is readily apparent from the initial CFD
simulations (the implementation of stirring movement via the
moving reference frame method and description of turbu-
lence using Launder and Spalding’s standard k–ε model).
This flow field is, however, more typical for pitched blade
impellers. Key engineering data of the Mobius CellReady
Bioreactor, which have been determined for relevant
cultivation conditions on the basis of the fluid flow and
subsequently experimentally verified (Table 2), were com-
parable to those of a standard cell culture bioreactor with
pitched blade impeller and sparger ring (such as the Biostat
B plus 2 L operating at the authors’ laboratory).
As expected, the first cultivations of CHO suspension
cells grown in chemically defined minimal culture media
(CHO Master HP-1 and HP-5, Cell Culture Technologies)
provided results for cell growth and product expression
comparable to those of the Biostat B plus. In the Mobius
CellReady Bioreactor, doubling times of 23 h, corresponding
to a maximum growth rate of 0.03 per hour, were achieved.
The maximum total cell density was 3.3 × 106 cells per
milliliter and the secreted alkaline phosphatase (SEAP)
activity was 4.9 U/mL (Fig. 2). Although further experi-
ments are planned, it can be concluded from these results
that the Mobius CellReady 3 L Bioreactor represents an
alternative to standard stirred cell culture bioreactors at
benchtop scale.
Table 2 Engineering key data of the Mobius CellReady 3 L
Bioreactor determined for relevant cultivation conditions
Parameter Symbol Unit Value
Rotational speed N rpm 80–120
Tip speed utip m s
−1 0.32–0.48
Specific power input " W m−3 0.83–3.06
Dissipation ratio "max=" – 130–115
Newton number Ne – 0.31
Mixing number θ95% – 34
Fig. 2 Time-dependent course of growth and product formation in the
case of biphasic cultivation of the SEAP expressing CHO XM 111-10
model cell line (established by the Fussenegger group, Swiss Federal
Institute of Technology Zurich) in the Mobius CellReady 3 L
Bioreactor. Growth phase was performed in feeding mode (mixture
of CHO Master HP-1 and HP-5 growth medium). Production phase
was induced after medium exchange (CHO Master HP-5 production
medium) and temperature shift from 37°C to 31°C. a Graphs of total
cell density (circle) and SEAP activity (diamond). b Graphs of
glucose (filled square) and lactate concentrations (empty square)
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Conclusions and future trends
The variety of disposable bioreactors currently available,
encompassing wave-mixed, orbitally shaken or stirred
reactors used to cultivate animal cells, and in a few cases
plant cells, from milliliter to cubic meter scale, have been
briefly reviewed. Microbial versions of the XDR-DSTB,
the CellMaker, and the CELL-tainer Bioreactor even allow
the usage of systems that have been specially designed for
growing microorganisms to high cell densities. Neverthe-
less, there are still limitations with regard to the measurement
range of the existing disposable sensors and scalability (three
digit range) for plant cell and microorganism cultivations.
Moreover, for plant cell and microorganism-derived produc-
tions, it should be noted that the application of disposable
bioreactors only becomes cost-effective for high-value
products due to the high cost of consumable material. On
the other hand, scalable, less-instrumented, low-cost ver-
sions such as the WUB are in demand for low-value
products.
The selection of a disposable bioreactor for animal cells
is dependent on a number of factors. Naturally, the
cultivation task (biomass or cell production, expression of
a biologically active substance) and the production cell line,
characterized by its morphology, growth, and production
behavior, have a strong impact on the selection of the
disposable bioreactor type. The scale of the bioreactor and
its engineering parameters, including fluid flow pattern,
mixing times, residence time distribution, volumetric
oxygen transfer rates, specific power input data, shear
stress distribution, etc., are also critical factors. For
example, numeric and experimental investigations of fluid
flow in wave-mixed bioreactors (Öncül et al. 2009; Eibl et
al. 2009b) demonstrate that laminar flow and thus low shear
stress exist when typical process parameters for animal cells
are presupposed. Furthermore, simulation studies suggest
that the time during which the cells are exposed to local
shear stress is lower than in stirred cell culture bioreactors
(Werner 2009), both of which could explain the apparent
superiority of wave-mixed bag bioreactors demonstrated in
certain studies with animal cells. Additional selection
factors, not to be underestimated, include the legal require-
ments with which the bioreactor must comply (biosafety,
GMP compliance), the capital and running costs and the
available infrastructure. The mutual trust between customer
and vendor and the know-how of staff in bioreactor
operation may also play important roles. The rapid
acceptance and widespread use of stirred disposable
bioreactors suggest that companies with experience of
stirred standard cell culture bioreactors prefer their stirred
disposable counterparts. An exception is the production of
inoculum where wave-mixed bioreactors still dominate.
The extent to which orbitally shaken disposable bioreactors
or novel versions, such as the pneumatically driven system
from PBS, will be utilized at production scale depends on
their cultivation results and their engineering data. The
availability of the appropriate engineering data will finally
allow a direct comparison with stirred systems, which
provide the benchmark for the majority of biotechnological
processes to date.
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